Heart Test Laboratories (NASDAQ:HSCS) Shares Up 4.1% – What’s Next?

Posted by Stanley Muller on May 4th, 2025

Heart Test Laboratories, Inc. (NASDAQ:HSCS – Get Free Report)’s share price traded up 4.1% on Friday . The company traded as high as $3.66 and last traded at $3.62. 10,637 shares traded hands during trading, a decline of 92% from the average session volume of 127,019 shares. The stock had previously closed at $3.48.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets reduced their target price on Heart Test Laboratories from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, March 18th.

Get Our Latest Stock Report on Heart Test Laboratories

Heart Test Laboratories Stock Performance

The stock has a market cap of $3.91 million, a price-to-earnings ratio of -0.46 and a beta of 2.71. The company has a quick ratio of 1.52, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. The company has a 50 day simple moving average of $3.14 and a 200 day simple moving average of $3.31.

Heart Test Laboratories (NASDAQ:HSCS – Get Free Report) last released its quarterly earnings data on Thursday, March 13th. The company reported ($2.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.53) by ($0.04). As a group, equities research analysts forecast that Heart Test Laboratories, Inc. will post -10.01 EPS for the current year.

Hedge Funds Weigh In On Heart Test Laboratories

A hedge fund recently bought a new stake in Heart Test Laboratories stock. Astoria Strategic Wealth Inc. acquired a new stake in Heart Test Laboratories, Inc. (NASDAQ:HSCS – Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 18,927 shares of the company’s stock, valued at approximately $53,000. Astoria Strategic Wealth Inc. owned about 1.75% of Heart Test Laboratories at the end of the most recent reporting period. Hedge funds and other institutional investors own 17.24% of the company’s stock.

Heart Test Laboratories Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.